The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital. Photo by Scott Morgan/AHA.
December 17, 2019
Most Popular Cardiology Technology Content in November 2019
December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC…
Read More
Vascepa pill contains a concentrated form of fish oil, icosapent ethyl, indication for prevention. The U.S. Food and Drug Administration (FDA) Dec. 13, 2019, approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels.
Dave Fornell, Editor
December 16, 2019
FDA Expands Vascepa to Reduce Cardiovascular Events in Elevated Triglyceride Patients
December 16, 2019 — The U.S. Food and Drug Administration (FDA), on Dec. 13, approved the use of Vascepa (icosapent…
Read More
impulse dynamics Optimizer for Heart failure.
December 12, 2019
Impulse Dynamics Secures $80.25 Million Financing
December 12, 2019 — Impulse Dynamics, developer of Optimizer Smart System for delivering CCM therapy, announced the…
Read More
aspirin bottle
December 12, 2019
Low-dose Aspirin May Not Help African Americans Prevent Heart Disease
December 12, 2019 — Low-dose aspirin was not associated with a reduced risk of a fatal heart attack among African…
Read More
Cardiologs
December 12, 2019
Cardiologs Earns Frost & Sullivan’s New Product Innovation Award
December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today…
Read More
DiA’s novel solution leverages AI to transform the way clinicians capture and analyze ultrasound images
December 09, 2019
DiA Joins with IBM Watson Health to Arm Clinicians with its AI-powered Cardiac Ultrasound Software
December 9, 2019 —  DiA Imaging Analysis Ltd., an IBM Alpha Zone Accelerator Alumni Startup, announces a collaboration…
Read More
CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers. #RSNA19 #RSNA2019
November 27, 2019
Augmented Reality for Radiology and Cardiology Training Demonstrated at RSNA 2019
November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and…
Read More
A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.
Saipriya Iyer
November 27, 2019
Developments in Transcatheter Mitral Valve Replacement
The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to…
Read More
The Philips Lumify hand-held ultrasound technology is an important component of the mobile ECMO unit. Members of the ECMO team use Lumify for real-time visual guidance when inserting tubes in veins and arteries in a process called ECMO cannulation. #RSNA2019 #RSNA19 #POCUS
November 26, 2019
Handheld Ultrasound Aids First Mobile ECMO Unit in a Pre-hospital Setting
November 26, 2019 — Physicians from the University of New Mexico (UNM) and local emergency responders recently treated…
Read More
A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.
Dave Fornell, Editor
November 26, 2019
TriClip Device For Tricuspid Regurgitation Effective at One Year in TRILUMINATE Study
November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a…
Read More
November 26, 2019
Virtual Study to Track Statin-Related Adverse Events Being Undertaken by University of Connecticut and Hartford Healthcare
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have…
Read More
The FDA cleared the IN.PACT AV drug-coated Balloon. Clinical data shows In.Pact AV DCB is Safe, reduces reinterventions and maintains access for end-stage renal disease patients undergoing dialysis
November 26, 2019
FDA Clears Medtronic Drug-Coated Balloon to Treat Arteriovenous Fistula Lesions
November 21, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated…
Read More
ECG
November 22, 2019
Artificial Intelligence Examining ECGs Predicts Irregular Heartbeat, Death Risk
November 22, 2019 — Artificial intelligence can examine electrocardiogram (ECG) test results, a common medical test, to…
Read More
This is 4MD’s cardiac nuclear imaging analysis software, shown here integrated with a ScImage cardiovascular information system (CVIS). Both companies displayed on the expo floor at ASNC 2019. The software creates a single page report seen here. PET perfusion imaging was a big topics at the conference. #ASNC #ASNC19 #ASNC2019
Dave Fornell, Editor
November 22, 2019
6 Trends in Cardiac Nuclear Imaging at the ASNC 2019 Meeting
There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September…
Read More
The three sites most often used for distal radial artery access are the (1) anatomic snuffbox above the scaphoid (left), (2) adjacent to the snuffbox at the trapezium bone (center), and (3) the first intermetacarpal space (right). The author’s preference is either of the first two options, although good outcomes have been reported with use of the intermetacarpal space.
Enrique Flores, M.D., RPVI
November 21, 2019
Incorporating Distal Radial Artery Access Into Clinical Practice
Interest in distal radial artery access (DRA) is growing rapidly. Among the benefits of DRA are the low risk of entry…
Read More
EKO digital stethoscopes
November 21, 2019
Eko and Mayo Clinic Prove Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope
November 21, 2019 — At the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying…
Read More
cardiac arrest cath lab
November 21, 2019
Weekend Sudden Cardiac Arrests are More Deadly
November 21, 2019 — People who experience cardiac arrests over the weekend are less likely to survive long enough to be…
Read More
The Cordella Pulmonary Artery Pressure Sensor System for Heart failure. #AHA19 #AHA
November 21, 2019
Positive Results for SIRONA First-in-Human Trial of the Cordella PA Pressure Sensor System
November 21, 2019 — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of…
Read More
Heart failure VICTORIA TrIal a success. Dave Fornell
November 21, 2019
Investigational Drug Vericiguat Reduced the Risk of Heart Failure Hospitalization in VICTORIA Trial
November 21, 2019 — Merck announced the results from the Phase 3 VICTORIA Study evaluating the efficacy and safety of…
Read More
heart disease
November 20, 2019
Heart Disease and Cancer Risk May be Linked
November 20, 2019 — Heart attack survivors may have an increased risk of developing cancer compared to people without…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now